David Hung

David T.
Hung was the founder of Medivation LLC (California), founded in 1995, serving as President, Chief Executive Officer & Director from 2003 to 2016.
Dr. Hung was the founder of Medivation, Inc., founded in 2003, serving as President, Chief Executive Officer & Director from 2003 to 2016.
Dr. Hung is the founder of Nuvation Bio Operating Co., Inc., founded in 2018, serving as President, Chief Executive Officer & Director since 2018.
Dr. Hung is the founder of Nuvation Bio, Inc., founded in 2018, serving as Chairman, President & Chief Executive Officer since 2024.
Dr. Hung is also the founder of Repharmation, Inc...
Current positions include Chairman at T-Therapeutics Ltd., Independent Director at NovoCure Ltd. since 2018, Director at Establishment Labs SA since 2016, and Director at Auransa, Inc. Former positions include President & Chief Executive Officer at Orion Acquisition Corp.
II; President, Chief Executive Officer & Director at Pro-Duct Health, Inc. from 1999 to 2001; President, Chief Executive Officer & Director at Medivation Neurology LLC from 2011 to 2016; Chief Executive Officer & Director at Sio Gene Therapies, Inc. from 2017 to 2018; Chief Executive Officer & Director at Axovant Sciences, Inc. from 2017 to 2018; Director at Agilvax, Inc.; Director at Solbec Pharmaceuticals Ltd.; Independent Director at Opexa Therapeutics, Inc. from 2010 to 2011; Director at NKT Therapeutics, Inc.; Director at Roivant Sciences GmbH; Independent Director at Establishment Labs Holdings, Inc. from 2016 to 2021; Independent Director at ARYA Sciences Acquisition Corp.
from 2018 to 2021; VP-Lead Discovery, Development & New Projects at Chiron Corp.
from 1996 to 1998; Consultant at Cytyc Health Corp.
in 2003.
Education includes undergraduate degree from Harvard College and doctorate from UCSF School of Medicine.